Magnevist Post-marketing Surveillance in Japan

Status Completed

Clinical Trial Summary

This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Magnevist at a dose of more than 0.2 ml/kg for MR angiography of peripheral vasculature with continuous imaging from the abdomen to the lower extremities. The objective of this study is to assess safety, especially in relation to renal dysfunction, and efficacy of using Magnevist in clinical practice. A total 2,000 patients will be recruited.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Diagnostic Imaging

Clinical Trial Details

NCT number	NCT01376739
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase	N/A
Start date	August 2007
Completion date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01415414` - Observational Study of Ultravist in Patients Requiring CECT	N/A
Terminated	`NCT00975299` - Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers	Phase 1
Not yet recruiting	`NCT05036460` - Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients	N/A
Recruiting	`NCT05610098` - Gene Expression Profiles in Spinal Tuberculosis.
Completed	`NCT01009359` - Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers	Phase 1
Completed	`NCT00244140` - Ultravist: Safety and Efficacy in Computed Tomography of Head and Body	Phase 3
Completed	`NCT02980081` - Abdominal Plain X-ray in the Emergency Departement	N/A
Completed	`NCT01205321` - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers	Phase 1
Recruiting	`NCT05823857` - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain	N/A
Recruiting	`NCT04859634` - Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Completed	`NCT03125629` - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals	Phase 2
Terminated	`NCT03167190` - Ultrasound-Assisted Lumbar Puncture	N/A
Completed	`NCT01297088` - PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.	Phase 1
Completed	`NCT01089998` - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations	Phase 1
Completed	`NCT00347022` - A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications	Phase 4
Completed	`NCT00876083` - PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination	N/A
Completed	`NCT01411449` - Primovist Post-marketing Surveillance in Japan	N/A
Completed	`NCT01153607` - Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers	Phase 1
Completed	`NCT00709852` - Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging	Phase 3
Terminated	`NCT00659776` - MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation	Phase 2